Release of USPSTF Final Recommendation on Screening for Prostate Cancer
Today, the U.S. Preventive Services Task Force released its prostate cancer screening final recommendation statement. The draft recommendation statement was posted online for public comment from October 11 to December 13, 2011. The USPSTF reviewed and considered the public comments received when the draft recommendation statement was posted. The final recommendation statement includes a section called "Response to Public Comments," which addresses the comment process and common themes from the public feedback received. To view the final recommendation statement and the supporting evidence reports, click here http://www.uspreventiveservicestaskforce.org/prostatecancerscreening.htm. A fact sheet that explains the final recommendation statement in plain language is also posted on that Web page.
U.S. Preventive Services
Current RecommendationRelease Date: May 2012
- The USPSTF recommends against PSA-based screening for prostate
Grade: D Recommendation.
|“Prostate cancer is a serious health problem that affects thousands of men
and their families. But before getting a PSA test, all men deserve to know what
the science tells us about PSA screening: there is a very small potential
benefit and significant potential harms. We encourage clinicians to consider
this evidence and not screen their patients with a PSA test unless the
individual being screened understands what is known about PSA screening and
makes the personal decision that even a small possibility of benefit outweighs
the known risk of harms.”|
—USPSTF Co-Chair Michael LeFevre, M.D., M.S.P.H.In October 2011, the USPSTF posted for public comment the draft of its recommendation regarding prostate cancer screening. Since then, Task Force members have read the many comments received and reviewed the most up-to-date evidence.
May 22, 2012
Based on this work, the Task Force concludes that many men are harmed as a result of prostate cancer screening and few, if any, benefit.
A better test and better treatment options are needed. Until these are available, the USPSTF has recommended against screening for prostate cancer.
The members of the USPSTF face the same concerns and fears about health challenges as other people. This decision was reached only after extensive consideration and thoughtful debate. It is based on science and rooted in the knowledge that while everyone wants to help prevent deaths from prostate cancer, current methods of PSA screening and treatment of screen-detected cancer are not the answer.
The mission of the USPSTF is to improve the health of all Americans by sharing with them evidence-based recommendations, and empowering them and the clinicians who serve them to make informed decisions.
|Supporting Document||Related Items|
|Are You Considering Being Screened? Facts for Consumers (PDF File, 293 KB; PDF Help)|
|Prostate Cancer Screening Statistics at a Glance (PDF File, 65 KB; PDF Help)|
|How Did the USPSTF Arrive at This Recommendation?|
|Clinical Summary (PDF File, 61 KB; PDF Help)|
|Talking With Your Patients About Screening for Prostate Cancer (PDF File, 243 KB; PDF Help)|
Recommendation Statement for Public Comment*|
(November 30–December 13, 2011)
|Evidence Report (PDF File, 169 KB; PDF Help)||Evidence Synthesis, Screening (PDF File, 783 KB; PDF Help)|
|Evidence Synthesis, Treatment (PDF File, 1.8 MB; PDF Help)|
* Note: Draft Recommendation Statements are by their nature not final, and should not be interepreted as to represent official USPSTF recommendations for practice. Draft Recommendation Statements are provided by the USPSTF for informational purposes only.
Current as of May 2012
Screening for Prostate Cancer, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/prostatecancerscreening.htm